Evidence item

The Nature Medicine abstract directly states the testing-cohort scope and separate low- and high-risk control groups. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 14222

Source: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma · locator {} · excerpt hash sha256:6356a3a1762f407e48526e7db9e58e7fa58a345cbdde84b8a3d0affab4af24af

When combined with carbohydrate antigen 19-9 levels, this blood assay demonstrated a sensitivity of 86.8% for stage I–II PDAC, false-positive rates of 3.2% in low-risk controls and 15.6% in high-risk controls in the testing cohort.